JP EQUITY · VALUATION FRAME · P/B REGIME · EDINET 369사369 COMPANIES369社

일본 주가는 이익이 아니라 장부를 따라간다 — 1배 아래는 ROE 를 따라 오르고, 1배 위는 ROE 가 꺾이면 끌려 내려온다Japanese share prices track book value, not earnings — below 1x they rise with ROE; above 1x they are dragged down when ROE turns日本の株価は利益ではなく簿価に連動する — 1倍未満はROEに沿って上がり、1倍超はROEが反転すると引き下げられる

P/B = P/E × ROE 다. 회사마다 ROE 가 변할 때 P/B 가 따라 움직이는지(기울기 1 = 이익을 따라감, 0 = 장부에 묶임)부터 재고, 주가가 BPS 와 EPS 중 무엇을 따라가는지, 배당·자사주가 언제 주가를 올리는지, 그리고 P/B 1배를 경계로 ROE 방향에 따라 주가가 어떻게 갈리는지를 같은 표본으로 잇는다. 한국도 같은 엔진·같은 순서로 잰다(→ 한국 페이지).P/B = P/E × ROE. We first measure whether P/B moves when each company’s ROE changes (slope 1 = tracks earnings, 0 = anchored to book), then, on the same sample, whether share prices track BPS or EPS, when dividends and buybacks lift prices, and how prices split by ROE direction on either side of P/B 1x. Korea is measured with the same engine in the same order (→ Korea page).P/B = P/E × ROEである。企業ごとにROEが変化したときP/Bが連動するか(傾き1 = 利益に連動、0 = 簿価に縛られる)をまず測り、 株価がBPSとEPSのどちらに連動するか、配当・自社株買いがいつ株価を押し上げるか、そしてP/B 1倍を境にROEの方向によって株価がどう分かれるかを 同じ標本でつなぐ。韓国も同じエンジン・同じ順序で測る(→ 韓国のページ)。

2026年09月25日現在 코드리스트 상장사 · 3월/12월 결산 · 업종 비례 무작위 418사(시드 20261019). 有報 5년 표 두 벌 = 회사당 최대 10개 연도. 주가는 그해 有報의 EPS × PER 로 역산한 가공값 — 적자 해(PER 미기재)는 빠진다(회사-연도의 11%). 회사 안 시계열로 재므로 업종·규모 차이는 지워진다. 시가총액 가중이 아니라 지수와 다르다. 3월 결산은 끝나는 해 − 1 을 FY 로(2026-03 = FY2025).2026年09月25日現在 코드리스트 상장사 · 3월/12월 결산 · 업종 비례 무작위 418사(시드 20261019). Two 5-year tables from annual securities reports = up to 10 years per company. Prices are derived values back-calculated as EPS × P/E from that year’s annual securities report — loss years (no P/E reported) are excluded (11% of company-years). Measuring within-company time series removes differences in industry and size. Not cap-weighted, so it differs from an index. 3월 결산은 끝나는 해 − 1 을 FY 로(2026-03 = FY2025).2026年09月25日現在 코드리스트 상장사 · 3월/12월 결산 · 업종 비례 무작위 418사(시드 20261019)。有報の5年表2つ = 1社あたり最大10年度。株価はその年の有報のEPS × PERから逆算した加工値 — 赤字の年(PER記載なし)は除外(企業・年度の11%)。 企業内の時系列で測るため、業種・規模の違いは消える。時価総額加重ではないため、指数とは異なる。3월 결산은 끝나는 해 − 1 을 FY 로(2026-03 = FY2025).

논리 사슬 — 일본 주가는 무엇을 따라가나Logic chain — what do Japanese share prices track?論理チェーン — 日本の株価は何に連動するか

각 단계의 숫자 = 아래 절Figures at each step = sections below各段階の数字 = 下の節 · Data as of 2026-03 · Created 2026-11-01
1
P/E 냐 P/B 냐P/E or P/BP/EかP/Bか
기울기 중앙 0.22Median slope 0.22傾きの中央値0.22
ROE 가 변해도 P/B 가 거의 그대로 — 장부 쪽 회사 67%, P/B 가 P/E 보다 덜 흔들린 회사 78%P/B barely moves as ROE changes — 67% of companies on the book side, 78% with P/B less volatile than P/EROEが変わってもP/Bはほぼ不変 — 簿価側の企業67%、P/BがP/Eより振れが小さい企業78%
→
2
주가는 BPS 를 따라간다Prices track BPS株価はBPSに連動する
BPS 1% ↔ 주가 0.98%BPS 1% ↔ price 0.98%BPS 1% ↔ 株価0.98%
EPS 1% ↔ 주가 0.15% — 그해 이익은 거의 안 실린다EPS 1% ↔ price 0.15% — same-year earnings are barely priced inEPS 1% ↔ 株価0.15% — その年の利益はほとんど織り込まれない
→
3
BPS 는 이익의 적분BPS is the integral of earningsBPSは利益の積分
ROE 1%p ↔ BPS 연 0.51%pROE 1pp ↔ BPS 0.51pp a yearROE 1%pt ↔ BPS 年0.51%pt
BPS = 쌓인 이익 − 환원 ± 자본 거래 — 엔진은 여전히 ROE(t +7.7)BPS = accumulated earnings − shareholder returns ± capital transactions — the engine is still ROE (t +7.7)BPS = 積み上がった利益 − 還元 ± 資本取引 — エンジンは依然としてROE(t +7.7)
→
4
환원은 1배 아래에서만 증폭Shareholder returns amplify only below 1x還元は1倍未満でのみ増幅
주식 10% 소각 → BPS +4.2% / -8.6%Cancel 10% of shares → BPS +4.2% / -8.6%株式10%消却 → BPS +4.2% / -8.6%
P/B 1배 아래 / 위 — 1배 위에서 사는 자사주는 BPS 를 깎는다(t -3.0)P/B below / above 1x — buybacks above 1x cut BPS (t -3.0)P/B 1倍未満 / 超 — 1倍超での自社株買いはBPSを削る(t -3.0)
→
5
레짐 — 1배가 갈림길Regime — 1x is the forkレジーム — 1倍が分かれ道
1배 위 + ROE↓ -11.4Above 1x + ROE↓ -11.41倍超 + ROE↓ -11.4
1배 아래 + ROE↑ +5.5 · 1배 아래 + ROE↓ -1.5 · 1배 위 + ROE↑ +1.7(로그pt)Below 1x + ROE↑ +5.5 · below 1x + ROE↓ -1.5 · above 1x + ROE↑ +1.7 (log pt)1倍未満 + ROE↑ +5.5 · 1倍未満 + ROE↓ -1.5 · 1倍超 + ROE↑ +1.7(対数pt)
→
6
ROE 기울기가 꺾이면When the ROE slope turnsROEの傾きが反転すると
1배 위 꺾임 -14.0 vs 지속 +2.3Above 1x: turn -14.0 vs continue +2.31倍超:反転-14.0 vs 継続+2.3
1배 아래에선 꺾이면 오름이 멈춘다(+0.0 vs +7.9)Below 1x, a turn stops the rise (+0.0 vs +7.9)1倍未満では反転すると上昇が止まる(+0.0 vs +7.9)
→
7
왜 — 이익을 사이클로 본다Why — earnings are seen as cyclicalなぜ — 利益をサイクルと見る
내수 1배 위 ROE↓ -6.5 → -16.8Domestic, above 1x, ROE↓ -6.5 → -16.8内需 1倍超 ROE↓ -6.5 → -16.8
앞 구간 → 최근: 내수도 경기민감처럼 값이 매겨진다 — 내수 회사 간 ROE 흩어짐은 거의 그대로다Earlier period → recent: domestic stocks are priced like cyclicals too — dispersion of ROE across domestic companies stayed about the same前期間 → 直近:内需も景気敏感株のように値付けされる — 内需企業間のROEのばらつきはほぼ変わらない
1배 아래 + ROE 기울기 ↑ (일본 +5.5) = 재평가 — 이익이 오르면 같이 오른다.Below 1x + ROE slope ↑ (Japan +5.5) = Re-rating — rises along with earnings.1倍未満 + ROEの傾き ↑(日本 +5.5)= 再評価 — 利益が上がると一緒に上がる。
1배 아래 + ROE 기울기 ↓ (일본 -1.5) = 바닥 — 장부가 받친다.Below 1x + ROE slope ↓ (Japan -1.5) = Floor — book value supports it.1倍未満 + ROEの傾き ↓(日本 -1.5)= 底 — 簿価が支える。
1배 위 + ROE 기울기 ↑ (일본 +1.7) = 상단 — 이익이 늘어도 더 안 붙는다.Above 1x + ROE slope ↑ (Japan +1.7) = Ceiling — no more premium even as earnings grow.1倍超 + ROEの傾き ↑(日本 +1.7)= 上限 — 利益が増えてもそれ以上は付かない。
1배 위 + ROE 기울기 ↓ (일본 -11.4) = 중력 — 장부 쪽으로 끌려 내려온다.Above 1x + ROE slope ↓ (Japan -11.4) = Gravity — dragged down towards book.1倍超 + ROEの傾き ↓(日本 -11.4)= 重力 — 簿価の方へ引き下げられる。
1년 P/B 변화 중앙값(로그pt, 시장 전체를 뺀 값). 관측 틀이지 매매 규칙이 아니다. ROE 는 분기(일본은 2024년 4월 뒤 반기) 공시라, 기울기를 공시보다 먼저 잡으려면 월간 추정(우리 Fcst)이 필요하다.Median 1-year change in P/B (log pt, net of the whole market). An observational frame, not a trading rule. ROE is disclosed quarterly (half-yearly in Japan since April 2024), so catching the slope before disclosures requires a monthly estimate (our Fcst).1年間のP/B変化の中央値(対数pt、市場全体を差し引いた値)。観測の枠組みであり売買ルールではない。ROEは四半期(日本は2024年4月以降は半期)開示のため、傾きを開示より先に捉えるには月次推計(当サイトFcst)が必要だ。

① P/E 냐 P/B 냐 — 회사 안에서 ROE 가 변할 때 P/B 가 따라가나P/E or P/B — does P/B follow when ROE changes within a company?P/EかP/Bか — 企業内でROEが変化したときP/Bは連動するか

회사 수Companies社数 · Data as of 2026-03 · Created 2026-11-01
일본 · 그해 ROE 기준 중앙값Japan · median on same-year ROE日本 · その年のROEベースの中央値
0.22
사분위 0.04~0.44 · 0 쪽(장부) 67% · 1 쪽(이익) 14%. 1 이면 ROE 가 변해도 P/E 가 그대로, 0 이면 P/B 가 그대로.Interquartile range 0.04~0.44 · near 0 (book) 67% · near 1 (earnings) 14%. At 1, P/E stays put as ROE changes; at 0, P/B stays put.四分位0.04~0.44 · 0側(簿価)67% · 1側(利益)14%。1ならROEが変わってもP/Eが不変、0ならP/Bが不変。
평탄화 ROE(3년 평균) 기준On smoothed ROE (3-year average)平準化ROE(3年平均)ベース
0.30
일시 이익을 걸러도 0 쪽이면 장부 닻이다. 0 쪽 53% · 1 쪽 30%.If it stays near 0 even after filtering out one-off profits, book value is the anchor. Near 0: 53% · near 1: 30%.一時的な利益を除いても0側なら簿価が錨である。0側53% · 1側30%。
어느 배수가 덜 흔들리나Which multiple is less volatileどちらの倍率が振れにくいか
78%
P/B 가 P/E 보다 덜 흔들린 회사 비율 — log 표준편차 중앙 P/B 0.26 vs P/E 0.43.Share of companies whose P/B was less volatile than P/E — median log standard deviation P/B 0.26 vs P/E 0.43.P/BがP/Eより振れが小さかった企業の比率 — log標準偏差の中央値 P/B 0.26 vs P/E 0.43。
시가총액 가중Cap-weighted時価総額加重
0.38
큰 종목일수록 무게를 더 주면 — 표본 시총 상위가 26%를 차지한다. 한국 같은 값 0.59 · 중앙값 0.10.Giving more weight to larger stocks — the largest stocks in the sample account for 26%. Korea: same measure 0.59 · median 0.10.大きい銘柄ほどウエートを大きくすると — 標本の時価総額上位が26%を占める。韓国の同じ値0.59 · 中央値0.10。
규모(시총)Size (market cap)規模(時価総額)회사Companies社数기울기 중앙Median slope傾きの中央値평탄화 기준Smoothed basis平準化ベース최근 P/B 중앙Latest median P/B直近のP/B中央値
소형 1/3Small (bottom 1/3)小型 1/31160.120.140.66
중형 1/3Mid (middle 1/3)中型 1/31160.280.420.92
대형 1/3Large (top 1/3)大型 1/31170.260.391.17
시가총액 상위Largest by market cap時価総額上位기울기Slope傾き비중Weightウエート관측Observations観測数
ソフトバンクグループ株式会社ソフトバンクグループ株式会社ソフトバンクグループ株式会社0.4014.3%6
三井物産株式会社三井物産株式会社三井物産株式会社0.2811.7%10
株式会社リクルートホールディングス株式会社リクルートホールディングス株式会社リクルートホールディングス0.156.3%10
パナソニックホールディングス株式会社パナソニックホールディングス株式会社パナソニックホールディングス株式会社0.204.2%10
MS&ADインシュアランスグループホールディングス株式会社MS&ADインシュアランスグループホールディングス株式会社MS&ADインシュアランスグループホールディングス株式会社0.564.1%10
SOMPOホールディングス株式会社SOMPOホールディングス株式会社SOMPOホールディングス株式会社0.123.7%10
株式会社第一ライフグループ株式会社第一ライフグループ株式会社第一ライフグループ0.333.6%10
株式会社ブリヂストン株式会社ブリヂストン株式会社ブリヂストン0.493.1%9
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Limitations: 회사마다 관측이 적어 회사별 기울기는 흔들린다 — 분포로 읽는다. 적자 기간은 P/E 가 없어 빠진다. 표본은 업종 비례 무작위(소형 포함)이고 시가총액 가중이 아니다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Limitations: Each company has few observations, so company-level slopes are unstable — read them as a distribution. Loss-making periods have no P/E and are excluded. The sample is industry-proportional random (small caps included) and not cap-weighted.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Limitations: 企業ごとの観測が少ないため、企業別の傾きは不安定 — 分布として読む。赤字の期間はP/Eがないため除外。標本は業種比例の無作為抽出(小型株を含む)で、時価総額加重ではない。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

② 주가는 장부를 따라간다 — BPS 1% vs EPS 1%Prices track book value — BPS 1% vs EPS 1%株価は簿価に連動する — BPS 1% vs EPS 1%

주가 변화 ÷ BPS·EPS 변화(기울기)Price change ÷ change in BPS/EPS (slope)株価変化 ÷ BPS・EPS変化(傾き) · Data as of 2026-03 (JP) · 2026-09-30 (KR) · Created 2026-11-01
일본 1년 · BPS 설명력Japan 1-year · explanatory power of BPS日本 1年 · BPSの説明力R² 0.25EPS R² 0.11
일본 4년 · 순위상관Japan 4 years · rank correlation日本 4年 · 順位相関BPS 0.51 · EPS 0.50길게 보면 이익이 BPS 로 쌓여 둘이 비슷해진다Over longer horizons earnings accumulate into BPS and the two converge長く見ると利益がBPSに積み上がり、両者は近づく
일본 4년 주가 변화의 분산Japan 4 years · variance of price changes日本 4年 株価変化の分散BPS 35% · P/B 65%회사 간 차이는 대부분 P/B 재평가에서 났다Most of the difference between companies came from P/B re-rating企業間の差の大半はP/Bの再評価から生じた
일본 4년 중앙값(로그)Japan 4 years median (log)日本 4年 中央値(対数)주가 +0.24Price +0.24株価+0.24BPS +0.27 · P/B -0.04
P/B 가 장부에 묶여 있으면 주가 = P/B × BPS 라 주가는 BPS 와 1:1 로 움직이고, 그해 이익(EPS)은 기울기가 작다. 전형적인 회사의 주가 변화는 BPS 성장과 비슷하고, 회사 간 차이는 P/B 가 다시 매겨지는 데서 난다.If P/B is anchored to book value, price = P/B × BPS, so the price moves 1:1 with BPS and same-year earnings (EPS) have a small slope. A typical company’s price change is similar to its BPS growth, and differences between companies arise from P/B being re-rated.P/Bが簿価に縛られていれば株価 = P/B × BPSなので、株価はBPSと1:1で動き、その年の利益(EPS)の傾きは小さい。典型的な企業の株価変化はBPSの成長と同程度で、企業間の差はP/Bの付け直しから生じる。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Source: DART, Financial Supervisory Service.
본 차트는 “한국거래소 통계정보”를 사용한 결과임
Limitations: 일본은 같은 有報 안의 주당 값(분할 소급 일치), 한국은 총액(시가총액·자본·순이익) 기준. 일본 주가는 EPS × PER 로 역산했다. 장기 창은 한국이 더 짧다. 한국 P/B = (보통주 + 우선주 시가총액 − 회사가 들고 있는 자사주 시가) ÷ 지배 자본. 보유 수량은 DART 자기주식 표(사업·반기보고서)이고, 보고서 사이 분기는 직전 수량을 이어 썼다(그 뒤 소각은 상장주식수 감소로 뺐다) — 분기 중 매입·처분은 다음 보고서에서야 반영된다. 자기주식 표를 기재 생략한 회사는 보정하지 못해 보통주 + 우선주 그대로다. 재무를 외화로 공시하는 분기(두산밥캣 2023Q4~)는 원화 시가총액과 단위가 달라 뺐다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Source: DART, Financial Supervisory Service.
본 차트는 “한국거래소 통계정보”를 사용한 결과임
Limitations: Japan uses per-share values within the same annual securities report (consistent with retroactive split adjustments); Korea uses totals (market cap, equity, net profit). Japanese prices were back-calculated as EPS × P/E. The long window is shorter for Korea. 한국 P/B = (보통주 + 우선주 시가총액 − 회사가 들고 있는 자사주 시가) ÷ 지배 자본. 보유 수량은 DART 자기주식 표(사업·반기보고서)이고, 보고서 사이 분기는 직전 수량을 이어 썼다(그 뒤 소각은 상장주식수 감소로 뺐다) — 분기 중 매입·처분은 다음 보고서에서야 반영된다. 자기주식 표를 기재 생략한 회사는 보정하지 못해 보통주 + 우선주 그대로다. 재무를 외화로 공시하는 분기(두산밥캣 2023Q4~)는 원화 시가총액과 단위가 달라 뺐다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Source: DART, Financial Supervisory Service.
본 차트는 “한국거래소 통계정보”를 사용한 결과임
Limitations: 日本は同じ有報内の1株当たりの値(分割の遡及修正と一致)、韓国は総額(時価総額・自己資本・純利益)ベース。日本の株価はEPS × PERで逆算した。長期の窓は韓国の方が短い。 한국 P/B = (보통주 + 우선주 시가총액 − 회사가 들고 있는 자사주 시가) ÷ 지배 자본. 보유 수량은 DART 자기주식 표(사업·반기보고서)이고, 보고서 사이 분기는 직전 수량을 이어 썼다(그 뒤 소각은 상장주식수 감소로 뺐다) — 분기 중 매입·처분은 다음 보고서에서야 반영된다. 자기주식 표를 기재 생략한 회사는 보정하지 못해 보통주 + 우선주 그대로다. 재무를 외화로 공시하는 분기(두산밥캣 2023Q4~)는 원화 시가총액과 단위가 달라 뺐다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

③ BPS 는 이익의 적분 — 엔진은 여전히 ROEBPS is the integral of earnings — the engine is still ROEBPSは利益の積分 — エンジンは依然としてROE

Data as of 2026-03 · Created 2026-11-01
평균 ROE 1%p ↔ BPS 성장(연)Average ROE 1pp ↔ BPS growth (per year)平均ROE 1%pt ↔ BPS成長(年)0.51%p0.51pp0.51%ptt +7.7 · R² 0.44 · n 697
한국Korea韓国0.68%p0.68pp0.68%ptt +13.9
BPS 의 변화 = 그동안의 이익 − 배당 ± 자사주·증자 ± 기타포괄손익(투자주식 평가차익·환산차). 이익(EPS)은 흐름, BPS 는 그 흐름이 쌓인 재고다. 시장은 흔들리는 흐름 대신 쌓인 재고에 값을 매기지만, 재고를 늘리는 건 결국 ROE 다 — 평균 ROE 가 1%p 높으면 BPS 가 해마다 그만큼 더 큰다(위 숫자 = 유보율이 섞인 기울기). 자본 계정이지만 이익과 떨어진 숫자가 아니다.Change in BPS = earnings over the period − dividends ± buybacks and share issues ± other comprehensive income (valuation gains on investment securities, translation differences). Earnings (EPS) are the flow; BPS is the stock that the flow builds up. The market prices the accumulated stock rather than the volatile flow, but what grows the stock is ultimately ROE — if average ROE is 1pp higher, BPS grows that much more each year (the figure above = a slope that mixes in the retention ratio). It is an equity account, but not a number detached from earnings.BPSの変化 = その間の利益 − 配当 ± 自社株・増資 ± その他の包括利益(投資有価証券の評価差額・換算差額)。利益(EPS)はフロー、BPSはそのフローが積み上がったストックである。市場は振れるフローではなく積み上がったストックに値を付けるが、ストックを増やすのは結局ROEだ — 平均ROEが1%pt高ければBPSは毎年それだけ多く増える(上の数字 = 内部留保率が混じった傾き)。資本勘定だが、利益と切り離された数字ではない。

④ 환원은 증폭기 — P/B 1배 아래에서만Shareholder returns are an amplifier — only below P/B 1x還元は増幅器 — P/B 1倍未満でのみ

주식 수 10% 감소당 BPS 변화, %Change in BPS per 10% reduction in share count, %株式数10%減少あたりのBPS変化、% · Data as of 2026-03 (JP) · 2026-09-30 (KR) · Created 2026-11-01
P/B 0.60 배가 그대로면If P/B stays at 0.60xP/Bが0.60倍のままなら
전액 환원Full payout全額還元ROE × 1.67
절반 환원Half payout半分還元ROE × 1.33
P/B 0.80 배가 그대로면If P/B stays at 0.80xP/Bが0.80倍のままなら
전액 환원Full payout全額還元ROE × 1.25
절반 환원Half payout半分還元ROE × 1.12
P/B 1.00 배가 그대로면If P/B stays at 1.00xP/Bが1.00倍のままなら
전액 환원Full payout全額還元ROE × 1.00
절반 환원Half payout半分還元ROE × 1.00
P/B 1.25 배가 그대로면If P/B stays at 1.25xP/Bが1.25倍のままなら
전액 환원Full payout全額還元ROE × 0.80
절반 환원Half payout半分還元ROE × 0.90
P/B 1.50 배가 그대로면If P/B stays at 1.50xP/Bが1.50倍のままなら
전액 환원Full payout全額還元ROE × 0.67
절반 환원Half payout半分還元ROE × 0.83
P/B 가 k 로 그대로라면 총수익 ≈ ROE × [1 + 환원율 × (1/k − 1)]. 장부가 1원을 k 원에 쳐주는 시장에서 그 1원을 주주에게 현금으로 돌려주면(배당) 1원이 되고, k 원에 사서 없애면(자사주) 남은 주식의 BPS 가 오른다 — 1배 아래에서만 이득이다. 1배에 닿으면 증폭이 사라지고, 1배 위에서 사는 자사주는 BPS 를 깎는다. 그래서 '계속'이 아니라 1배까지다.If P/B stays at k, total return ≈ ROE × [1 + payout ratio × (1/k − 1)]. In a market that prices 1 unit of book value at k, returning that unit to shareholders in cash (dividends) is worth 1, while buying back at k and cancelling (buybacks) raises the BPS of the remaining shares — a gain only below 1x. At 1x the amplification disappears, and buybacks above 1x cut BPS. So it works up to 1x, not ‘indefinitely’.P/Bがkのままなら総リターン ≈ ROE × [1 + 還元率 × (1/k − 1)]。簿価1円をk円と評価する市場で、その1円を株主に現金で返せば(配当)1円になり、k円で買って消却すれば(自社株)残った株式のBPSが上がる — 1倍未満でのみ得になる。1倍に達すると増幅は消え、1倍超での自社株買いはBPSを削る。だから「ずっと」ではなく1倍までだ。
일본 1배 아래 · 주식 10% 감소 → BPSJapan below 1x · 10% fewer shares → BPS日本 1倍未満 · 株式10%減少 → BPS+4.2%t +2.8 · n 164
일본 1배 위 · 주식 10% 감소 → BPSJapan above 1x · 10% fewer shares → BPS日本 1倍超 · 株式10%減少 → BPS-8.6%t -3.0 · n 73
일본 1배 아래 · 주식 10% 감소 → 주가Japan below 1x · 10% fewer shares → price日本 1倍未満 · 株式10%減少 → 株価+10.4%t +1.9
일본 배당수익률 1%p ↔ 주가Japan dividend yield 1pp ↔ price日本 配当利回り1%pt ↔ 株価+8.5 로그pt+8.5 log pt+8.5 対数ptt +3.5 · 관측 기간 누적t +3.5 · cumulative over the observation periodt +3.5 · 観測期間累計
일본 배당수익률 5분위 — 주가 · BPS · P/B 변화(로그pt)Japan dividend-yield quintiles — change in price · BPS · P/B (log pt)日本 配当利回り5分位 — 株価・BPS・P/Bの変化(対数pt) · Data as of 2026-03 · Created 2026-11-01
일본: 최고 배당 5분위 주가 +67 · P/B +34 vs 최저 5분위 주가 +12 · P/B -22(로그pt). BPS 변화는 +35 ~ +33. 일본에선 배당이 P/B 재평가와 같이 갔다.Japan: highest dividend quintile price +67 · P/B +34 vs lowest quintile price +12 · P/B -22 (log pt). BPS change +35 ~ +33. In Japan, dividends went together with P/B re-rating.日本:配当最上位5分位 株価+67 · P/B +34 vs 最下位5分位 株価+12 · P/B -22(対数pt)。BPSの変化は+35 ~ +33。日本では配当がP/Bの再評価と連動した。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Source: DART, Financial Supervisory Service.
본 차트는 “한국거래소 통계정보”를 사용한 결과임
Limitations: 자사주 = 주식 수 감소(일본 평균 주식 수 · 한국 연말 주식 수). 분할·대규모 발행 회사는 뺐다. 일본과 한국의 관측 기간이 다르다. 인과가 아니라 동행이다. 고배당 회사는 출발 P/B 가 낮아 재평가의 일부는 평균회귀다. 도쿄거래소가 저P/B 기업을 압박한 한 시기의 관측이다. 분할 회사는 뺐다. 한국 P/B = (보통주 + 우선주 시가총액 − 회사가 들고 있는 자사주 시가) ÷ 지배 자본. 보유 수량은 DART 자기주식 표(사업·반기보고서)이고, 보고서 사이 분기는 직전 수량을 이어 썼다(그 뒤 소각은 상장주식수 감소로 뺐다) — 분기 중 매입·처분은 다음 보고서에서야 반영된다. 자기주식 표를 기재 생략한 회사는 보정하지 못해 보통주 + 우선주 그대로다. 재무를 외화로 공시하는 분기(두산밥캣 2023Q4~)는 원화 시가총액과 단위가 달라 뺐다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Source: DART, Financial Supervisory Service.
본 차트는 “한국거래소 통계정보”를 사용한 결과임
Limitations: Buybacks = reduction in share count (average shares for Japan · year-end shares for Korea). Companies with splits or large issues are excluded. Japan and Korea cover different observation periods. Co-movement, not causation. High-dividend companies start from a low P/B, so part of the re-rating is mean reversion. This is an observation from one period in which the Tokyo Stock Exchange pressed low-P/B companies. Companies with splits are excluded. 한국 P/B = (보통주 + 우선주 시가총액 − 회사가 들고 있는 자사주 시가) ÷ 지배 자본. 보유 수량은 DART 자기주식 표(사업·반기보고서)이고, 보고서 사이 분기는 직전 수량을 이어 썼다(그 뒤 소각은 상장주식수 감소로 뺐다) — 분기 중 매입·처분은 다음 보고서에서야 반영된다. 자기주식 표를 기재 생략한 회사는 보정하지 못해 보통주 + 우선주 그대로다. 재무를 외화로 공시하는 분기(두산밥캣 2023Q4~)는 원화 시가총액과 단위가 달라 뺐다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Source: DART, Financial Supervisory Service.
본 차트는 “한국거래소 통계정보”를 사용한 결과임
Limitations: 自社株 = 株式数の減少(日本は期中平均株式数 · 韓国は年末株式数)。分割・大規模発行のあった企業は除いた。日本と韓国で観測期間が異なる。因果ではなく連動である。 高配当企業は出発時のP/Bが低く、再評価の一部は平均回帰である。東京証券取引所が低P/B企業に圧力をかけた一時期の観測だ。分割のあった企業は除いた。 한국 P/B = (보통주 + 우선주 시가총액 − 회사가 들고 있는 자사주 시가) ÷ 지배 자본. 보유 수량은 DART 자기주식 표(사업·반기보고서)이고, 보고서 사이 분기는 직전 수량을 이어 썼다(그 뒤 소각은 상장주식수 감소로 뺐다) — 분기 중 매입·처분은 다음 보고서에서야 반영된다. 자기주식 표를 기재 생략한 회사는 보정하지 못해 보통주 + 우선주 그대로다. 재무를 외화로 공시하는 분기(두산밥캣 2023Q4~)는 원화 시가총액과 단위가 달라 뺐다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑤ 레짐 — P/B 1배가 갈림길Regime — P/B 1x is the forkレジーム — P/B 1倍が分かれ道

1년 P/B 변화 중앙값, 로그pt(시장 전체 뺀 값)Median 1-year P/B change, log pt (net of the whole market)1年間のP/B変化の中央値、対数pt(市場全体を差し引いた値) · Data as of 2026-03 (JP) · 2026-09-30 (KR) · Created 2026-11-01
일본Japan日本P/B 변화(로그pt)P/B change (log pt)P/B変化(対数pt)내린 비율Share that fell下落した比率관측Observations観測数읽기Reading読み
1배 아래 · ROE↑Below 1x · ROE↑1倍未満 · ROE↑+5.536%869재평가 — 이익이 오르면 같이 오른다Re-rating — rises along with earnings再評価 — 利益が上がると一緒に上がる
1배 아래 · ROE↓Below 1x · ROE↓1倍未満 · ROE↓-1.553%789바닥 — 장부가 받친다Floor — book value supports it底 — 簿価が支える
1배 위 · ROE↑Above 1x · ROE↑1倍超 · ROE↑+1.748%570상단 — 이익이 늘어도 더 안 붙는다Ceiling — no more premium even as earnings grow上限 — 利益が増えてもそれ以上は付かない
1배 위 · ROE↓Above 1x · ROE↓1倍超 · ROE↓-11.468%599중력 — 장부 쪽으로 끌려 내려온다Gravity — dragged down towards book重力 — 簿価の方へ引き下げられる
일본 관측 2827 · 시작 때 1배 위 41%. 회귀(기간 군집 표준오차): 같은 기간 ROE 1%p ↑ → P/B 1배 아래 +1.43(t +8.2) · 1배 위 +1.35(t +7.6) 로그pt, 시작 P/B 가 높을수록 내려온다(t -3.4). 한국: 1배 위 · ROE↓ -10.7 · 1배 아래 · ROE↑ +10.5.Japan: 2827 observations · 41% above 1x at the start. Regression (period-clustered standard errors): ROE up 1pp in the same period → P/B below 1x +1.43 (t +8.2) · above 1x +1.35 (t +7.6) log pt; the higher the starting P/B, the more it comes down (t -3.4). Korea: above 1x · ROE↓ -10.7 · below 1x · ROE↑ +10.5.日本 観測2827 · 開始時に1倍超41%。回帰(期間クラスター標準誤差):同期間のROE 1%pt ↑ → P/B 1倍未満+1.43(t +8.2)· 1倍超+1.35(t +7.6)対数pt、開始時のP/Bが高いほど下がる(t -3.4)。韓国:1倍超 · ROE↓ -10.7 · 1倍未満 · ROE↑ +10.5。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Source: DART, Financial Supervisory Service.
본 차트는 “한국거래소 통계정보”를 사용한 결과임
Limitations: 기간마다 시장 전체 중앙값을 뺀 1년 변화다. 일본은 연간 보고서, 한국은 겹치는 4분기 보폭이다. ROE 는 기간이 끝난 뒤 공시되므로 움직임 일부는 공시 전에 일어난다. 적자 기간은 P/B 가 비어 빠진다. 한국 P/B = (보통주 + 우선주 시가총액 − 회사가 들고 있는 자사주 시가) ÷ 지배 자본. 보유 수량은 DART 자기주식 표(사업·반기보고서)이고, 보고서 사이 분기는 직전 수량을 이어 썼다(그 뒤 소각은 상장주식수 감소로 뺐다) — 분기 중 매입·처분은 다음 보고서에서야 반영된다. 자기주식 표를 기재 생략한 회사는 보정하지 못해 보통주 + 우선주 그대로다. 재무를 외화로 공시하는 분기(두산밥캣 2023Q4~)는 원화 시가총액과 단위가 달라 뺐다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Source: DART, Financial Supervisory Service.
본 차트는 “한국거래소 통계정보”를 사용한 결과임
Limitations: 1-year changes net of the whole-market median for each period. Japan uses annual reports; Korea uses overlapping four-quarter steps. ROE is disclosed after the period ends, so part of the move happens before disclosure. Loss-making periods have no P/B and are excluded. 한국 P/B = (보통주 + 우선주 시가총액 − 회사가 들고 있는 자사주 시가) ÷ 지배 자본. 보유 수량은 DART 자기주식 표(사업·반기보고서)이고, 보고서 사이 분기는 직전 수량을 이어 썼다(그 뒤 소각은 상장주식수 감소로 뺐다) — 분기 중 매입·처분은 다음 보고서에서야 반영된다. 자기주식 표를 기재 생략한 회사는 보정하지 못해 보통주 + 우선주 그대로다. 재무를 외화로 공시하는 분기(두산밥캣 2023Q4~)는 원화 시가총액과 단위가 달라 뺐다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Source: DART, Financial Supervisory Service.
본 차트는 “한국거래소 통계정보”를 사용한 결과임
Limitations: 期間ごとに市場全体の中央値を差し引いた1年間の変化。日本は年次報告書、韓国は重なる4四半期刻み。ROEは期間終了後に開示されるため、動きの一部は開示前に起きる。赤字の期間はP/Bが空欄のため除外。 한국 P/B = (보통주 + 우선주 시가총액 − 회사가 들고 있는 자사주 시가) ÷ 지배 자본. 보유 수량은 DART 자기주식 표(사업·반기보고서)이고, 보고서 사이 분기는 직전 수량을 이어 썼다(그 뒤 소각은 상장주식수 감소로 뺐다) — 분기 중 매입·처분은 다음 보고서에서야 반영된다. 자기주식 표를 기재 생략한 회사는 보정하지 못해 보통주 + 우선주 그대로다. 재무를 외화로 공시하는 분기(두산밥캣 2023Q4~)는 원화 시가총액과 단위가 달라 뺐다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑥ ROE 기울기가 꺾이면 — 1배 아래는 멈추고, 1배 위는 떨어진다When the ROE slope turns — below 1x it stalls, above 1x it dropsROEの傾きが反転すると — 1倍未満は止まり、1倍超は下落する

ROE 가 오르던 회사의 다음 1년 P/B 변화, 로그ptNext-year P/B change of companies whose ROE had been rising, log ptROEが上昇していた企業の翌1年のP/B変化、対数pt · Data as of 2026-03 (JP) · 2026-09-30 (KR) · Created 2026-11-01
일본: 1배 위에서 ROE 가 꺾이면 -14.0(n 296) vs 계속 오르면 +2.3(n 280) · 1배 아래 +0.0 vs +7.9. 이미 알려진(앞 기간) ROE 변화의 계수: 1배 위 -0.34(t -2.6) — 지난 이익 증가를 다음 해에 깎는다(사이클로 본다). 움직임은 ROE 가 알려지는 때 같이 오므로, 기울기는 공시와 같은 빈도로 잡아야 한다.Japan: above 1x, when ROE turns -14.0 (n 296) vs when it keeps rising +2.3 (n 280) · below 1x +0.0 vs +7.9. Coefficient on the already-known (previous-period) ROE change: above 1x -0.34 (t -2.6) — past earnings growth is marked down the following year (earnings are seen as cyclical). The move comes when ROE becomes known, so the slope has to be captured at the same frequency as disclosures.日本:1倍超でROEが反転すると-14.0(n 296)vs 上昇が続くと+2.3(n 280)· 1倍未満+0.0 vs +7.9。既知の(前期間の)ROE変化の係数:1倍超-0.34(t -2.6)— 過去の利益増加を翌年に割り引く(サイクルと見る)。 動きはROEが判明する時に一緒に来るため、傾きは開示と同じ頻度で捉える必要がある。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Source: DART, Financial Supervisory Service.
본 차트는 “한국거래소 통계정보”를 사용한 결과임
Limitations: 꺾임 = 앞 보폭에 ROE 가 오르고 이번 보폭에 내린 경우, 지속 = 두 보폭 모두 오른 경우. 한국은 관측 기간이 짧아 표본이 작다. 기간마다 시장 전체 중앙값을 뺐다. 한국 P/B = (보통주 + 우선주 시가총액 − 회사가 들고 있는 자사주 시가) ÷ 지배 자본. 보유 수량은 DART 자기주식 표(사업·반기보고서)이고, 보고서 사이 분기는 직전 수량을 이어 썼다(그 뒤 소각은 상장주식수 감소로 뺐다) — 분기 중 매입·처분은 다음 보고서에서야 반영된다. 자기주식 표를 기재 생략한 회사는 보정하지 못해 보통주 + 우선주 그대로다. 재무를 외화로 공시하는 분기(두산밥캣 2023Q4~)는 원화 시가총액과 단위가 달라 뺐다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Source: DART, Financial Supervisory Service.
본 차트는 “한국거래소 통계정보”를 사용한 결과임
Limitations: Turn = ROE rose in the previous step and fell in this one; continue = it rose in both steps. Korea’s observation period is short, so the sample is small. The whole-market median for each period is subtracted. 한국 P/B = (보통주 + 우선주 시가총액 − 회사가 들고 있는 자사주 시가) ÷ 지배 자본. 보유 수량은 DART 자기주식 표(사업·반기보고서)이고, 보고서 사이 분기는 직전 수량을 이어 썼다(그 뒤 소각은 상장주식수 감소로 뺐다) — 분기 중 매입·처분은 다음 보고서에서야 반영된다. 자기주식 표를 기재 생략한 회사는 보정하지 못해 보통주 + 우선주 그대로다. 재무를 외화로 공시하는 분기(두산밥캣 2023Q4~)는 원화 시가총액과 단위가 달라 뺐다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Source: DART, Financial Supervisory Service.
본 차트는 “한국거래소 통계정보”를 사용한 결과임
Limitations: 反転 = 前の刻みでROEが上がり今回の刻みで下がった場合、継続 = 両方の刻みで上がった場合。韓国は観測期間が短く標本が小さい。期間ごとに市場全体の中央値を差し引いた。 한국 P/B = (보통주 + 우선주 시가총액 − 회사가 들고 있는 자사주 시가) ÷ 지배 자본. 보유 수량은 DART 자기주식 표(사업·반기보고서)이고, 보고서 사이 분기는 직전 수량을 이어 썼다(그 뒤 소각은 상장주식수 감소로 뺐다) — 분기 중 매입·처분은 다음 보고서에서야 반영된다. 자기주식 표를 기재 생략한 회사는 보정하지 못해 보통주 + 우선주 그대로다. 재무를 외화로 공시하는 분기(두산밥캣 2023Q4~)는 원화 시가총액과 단위가 달라 뺐다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑦ 왜 중력인가 — 내수도 경기민감처럼 값이 매겨진다Why gravity — domestic stocks are priced like cyclicals tooなぜ重力か — 内需も景気敏感株のように値付けされる

1년 P/B 변화 중앙값, 로그ptMedian 1-year P/B change, log pt1年間のP/B変化の中央値、対数pt · Data as of 2026-03 · Created 2026-11-01
일본 내수·방어 1배 위: ROE↑ +5.4 → -4.0 · ROE↓ -6.5 → -16.8(앞 구간 → FY2022~(도쿄증권거래소가 저P/B 기업에 개선을 요구하기 시작한 무렵부터)). 예전엔 이익이 오르면 P/E 를 쳐줬지만 최근엔 이익이 올라도 끌려 내려온다 — 수출·소재 업종이 원래 받던 대접이다.Japan domestic & defensive, above 1x: ROE↑ +5.4 → -4.0 · ROE↓ -6.5 → -16.8 (earlier period → FY2022~). Earnings growth used to earn a P/E, but recently prices are dragged down even when earnings rise — the treatment export and materials sectors always used to get.日本の内需・ディフェンシブ 1倍超:ROE↑ +5.4 → -4.0 · ROE↓ -6.5 → -16.8(前期間 → FY2022~)。以前は利益が上がればP/Eを付けたが、最近は利益が上がっても引き下げられる — 輸出・素材業種がもともと受けていた扱いだ。
일본 내수·방어 업종 회사 간 ROE 흩어짐(사분위폭, %p) — '양극화'가 이익에서 보이나Japan domestic & defensive: dispersion of ROE across companies (interquartile range, pp) — is ‘polarisation’ visible in earnings?日本 内需・ディフェンシブ業種の企業間ROEのばらつき(四分位範囲、%pt)— 「二極化」は利益に見えるか · Data as of 2026-03 · Created 2026-11-01
내수 회사 간 ROE 흩어짐은 2016 8.4 → 2025 8.2%p(최대 2018 10.6) — 거의 그대로다. 바뀐 건 내수 기업의 이익이 아니라 시장이 그 이익에 값을 매기는 방식이다.Dispersion of ROE across domestic companies: 2016 8.4 → 2025 8.2pp (max 2018 10.6) — stayed about the same. What changed is not domestic companies’ earnings but the way the market prices those earnings.内需企業間のROEのばらつきは2016 8.4 → 2025 8.2%pt(最大2018 10.6)— ほぼ変わらない。変わったのは内需企業の利益ではなく、市場がその利益に値を付ける方法だ。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Limitations: 수출·소재 = 提出者業種 16업종, 나머지 = 내수·방어·금융. 최근 구간은 관측 수가 적다. 기간마다 시장 전체 중앙값을 뺐다. 회사 간 ROE 수준의 사분위폭이다(적자 포함). 연간 보고서 기준.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Limitations: Export & materials = 16 filer industries (提出者業種); the rest = domestic, defensive and financial. The recent period has few observations. The whole-market median for each period is subtracted. Interquartile range of ROE levels across companies (loss-makers included). Based on annual reports.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Limitations: 輸出・素材 = 提出者業種16業種、残り = 内需・ディフェンシブ・金融。直近の期間は観測数が少ない。期間ごとに市場全体の中央値を差し引いた。 企業間のROE水準の四分位範囲(赤字を含む)。年次報告書ベース。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑧ 한·일 — 같은 ROE 에서 P/B, 그리고 환원 행태Korea vs Japan — P/B at the same ROE, and shareholder-return behaviour韓日 — 同じROEでのP/B、そして還元行動

ROE 구간별 P/B 중앙값, 배Median P/B by ROE band, xROE区間別のP/B中央値、倍 · KR FY2025 연말 · JP 2026-03KR FY2025 연말 · JP 2026-03KR FY2025 연말 · JP 2026-03 · Created 2026-11-17
연말Year-end年末시장Market市場회사Companies社数P/B 중앙Median P/BP/B中央値1배 미만Below 1x1倍未満ROE 중앙Median ROEROE中央値배당수익률Dividend yield配当利回り배당성향Payout ratio配当性向2년 주식 수 2%↑ 감소Share count down 2%+ over 2 years2年で株式数2%以上減少
2024한국(대·중형)Korea (large & mid caps)韓国(大型・中型)2210.8653% 7.1%———
2024일본(표본 전체)Japan (whole sample)日本(標本全体)3820.8562% 7.3%3.4%35%—
2024일본 대형 1/3Japan large (top 1/3)日本 大型1/31181.0547% 9.0%3.1%35%—
2025한국(대·중형)Korea (large & mid caps)韓国(大型・中型)2231.1148% 7.1%2.0%29%19%
2025일본(표본 전체)Japan (whole sample)日本(標本全体)3820.9654% 7.7%3.2%36%31%
2025일본 대형 1/3Japan large (top 1/3)日本 大型1/31181.1736% 9.5%2.7%39%47%
수익성은 비슷하다(ROE 중앙 한국 7.1% · 일본 7.7%, 일본 대형 9.5%). 같은 ROE 구간에서 2025년 말엔 4개 중 4개 구간에서 한국 P/B 가 더 높았다. 확실히 다른 건 환원 행태 — 배당성향 일본 36% vs 한국 29%, 2년간 주식 수를 줄인 회사 일본 31%(대형 47%) vs 한국 19%.Profitability is similar (median ROE Korea 7.1% · Japan 7.7%, Japan large 9.5%). Within the same ROE bands, Korean P/B was higher at end-2025 in 4 of 4 bands. What clearly differs is shareholder-return behaviour — payout ratio Japan 36% vs Korea 29%; companies that cut their share count over 2 years Japan 31% (large 47%) vs Korea 19%.収益性は似ている(ROE中央値 韓国7.1% · 日本7.7%、日本大型9.5%)。同じROE区間で、2025年末には4区間中4区間で韓国のP/Bの方が高かった。はっきり違うのは還元行動 — 配当性向 日本36% vs 韓国29%、2年間で株式数を減らした企業 日本31%(大型47%)vs 韓国19%。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Source: DART, Financial Supervisory Service.
본 차트는 “한국거래소 통계정보”를 사용한 결과임
Limitations: 한국 = 밸류 유니버스 대·중형 · 일본 = 업종 비례 무작위 표본(소형 포함) — 규모가 다르다. 한국 연말 시총은 2026년 10월 하락 전. 일본 회계연도는 3월·12월 결산이 섞여 있다. 한국 배당 원장은 FY2025 한 해뿐이다. 한국 P/B = (보통주 + 우선주 시가총액 − 회사가 들고 있는 자사주 시가) ÷ 지배 자본. 보유 수량은 DART 자기주식 표(사업·반기보고서)이고, 보고서 사이 분기는 직전 수량을 이어 썼다(그 뒤 소각은 상장주식수 감소로 뺐다) — 분기 중 매입·처분은 다음 보고서에서야 반영된다. 자기주식 표를 기재 생략한 회사는 보정하지 못해 보통주 + 우선주 그대로다. 재무를 외화로 공시하는 분기(두산밥캣 2023Q4~)는 원화 시가총액과 단위가 달라 뺐다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Source: DART, Financial Supervisory Service.
본 차트는 “한국거래소 통계정보”를 사용한 결과임
Limitations: 한국 = 밸류 유니버스 대·중형 · 일본 = 업종 비례 무작위 표본(소형 포함) — 규모가 다르다. 한국 연말 시총은 2026년 10월 하락 전. Japanese fiscal years mix March and December year-ends. The Korean dividend ledger covers FY2025 only. 한국 P/B = (보통주 + 우선주 시가총액 − 회사가 들고 있는 자사주 시가) ÷ 지배 자본. 보유 수량은 DART 자기주식 표(사업·반기보고서)이고, 보고서 사이 분기는 직전 수량을 이어 썼다(그 뒤 소각은 상장주식수 감소로 뺐다) — 분기 중 매입·처분은 다음 보고서에서야 반영된다. 자기주식 표를 기재 생략한 회사는 보정하지 못해 보통주 + 우선주 그대로다. 재무를 외화로 공시하는 분기(두산밥캣 2023Q4~)는 원화 시가총액과 단위가 달라 뺐다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Source: DART, Financial Supervisory Service.
본 차트는 “한국거래소 통계정보”를 사용한 결과임
Limitations: 한국 = 밸류 유니버스 대·중형 · 일본 = 업종 비례 무작위 표본(소형 포함) — 규모가 다르다. 한국 연말 시총은 2026년 10월 하락 전. 日本の会計年度は3月決算と12月決算が混在する。韓国の配当台帳はFY2025の1年分のみ。 한국 P/B = (보통주 + 우선주 시가총액 − 회사가 들고 있는 자사주 시가) ÷ 지배 자본. 보유 수량은 DART 자기주식 표(사업·반기보고서)이고, 보고서 사이 분기는 직전 수량을 이어 썼다(그 뒤 소각은 상장주식수 감소로 뺐다) — 분기 중 매입·처분은 다음 보고서에서야 반영된다. 자기주식 표를 기재 생략한 회사는 보정하지 못해 보통주 + 우선주 그대로다. 재무를 외화로 공시하는 분기(두산밥캣 2023Q4~)는 원화 시가총액과 단위가 달라 뺐다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

부록 — 일본 표본 세부(업종 · 해마다 단면 · 우리가 보는 종목)Appendix — Japan sample details (industries · annual cross-sections · stocks we follow)付録 — 日本の標本の詳細(業種・年ごとの断面・当サイトがフォローする銘柄)

⑨ 업종별By industry業種別

β 중앙값Median ββ中央値 · Data as of 2026-03 · Created 2026-11-01
차트는 회사 수가 적은 업종을 뺐고, 표는 전부 싣는다. 회사 간 차이를 지운 회사 안 기울기의 업종별 중앙값이다.The chart leaves out industries with few companies; the table lists them all. These are industry medians of within-company slopes, which remove differences between companies.チャートは企業数の少ない業種を除き、表はすべて載せる。企業間の違いを取り除いた企業内の傾きの業種別中央値である。
업종(提出者業種)Industry (filer industry)業種(提出者業種)회사Companies社数β 중앙값Median ββ中央値β₃ 중앙값Median β₃β₃中央値중앙 P/B(최근)Median P/B (latest)P/B中央値(直近)
電気・ガス業Electric Power & Gas電気・ガス業4-0.13-0.290.88
その他製品Other Productsその他製品9-0.02-0.260.69
非鉄金属Nonferrous Metals非鉄金属5-0.01-0.520.73
鉄鋼Iron & Steel鉄鋼70.030.080.68
その他金融業Other Financing Businessその他金融業40.040.900.76
サービス業Servicesサービス業290.090.191.52
パルプ・紙Pulp & Paperパルプ・紙40.09-0.380.46
金属製品Metal Products金属製品110.090.140.52
陸運業Land Transportation陸運業90.110.000.80
医薬品Pharmaceutical医薬品60.140.420.99
海運業Marine Transportation海運業40.140.110.81
倉庫・運輸関連Warehousing & Harbor Transportation Services倉庫・運輸関連50.14-0.800.54
食料品Foods食料品130.170.111.24
小売業Retail Trade小売業120.170.551.53
証券、商品先物取引業Securities & Commodity Futures証券、商品先物取引業40.180.391.15
石油・石炭製品Oil & Coal Products石油・石炭製品40.190.450.97
不動産業Real Estate不動産業100.200.380.92
卸売業Wholesale Trade卸売業340.200.370.93
機械Machinery機械290.220.420.87
電気機器Electric Appliances電気機器260.260.381.04
繊維製品Textiles & Apparels繊維製品50.27-0.321.02
空運業Air Transportation空運業20.28—0.98
化学Chemicals化学260.280.360.67
鉱業Mining鉱業40.311.021.15
精密機器Precision Instruments精密機器60.320.180.89
情報・通信業Information & Communication情報・通信業350.320.301.79
輸送用機器Transportation Equipment輸送用機器120.330.440.59
建設業Construction建設業190.350.071.10
ゴム製品Rubber Productsゴム製品40.350.400.90
保険業Insurance保険業40.440.881.22
ガラス・土石製品Glass & Ceramics Productsガラス・土石製品70.450.210.71
水産・農林業Fishery, Agriculture & Forestry水産・農林業40.470.731.14
銀行業Banks銀行業120.600.750.52
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Limitations: 회사 수가 적은 업종은 중앙값이 흔들린다 · 업종은 EDINET 코드리스트의 提出者業種.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Limitations: Medians are unstable for industries with few companies · industries are the filer industries (提出者業種) in the EDINET code list.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Limitations: 企業数の少ない業種は中央値が不安定 · 業種はEDINETコードリストの提出者業種。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑩ 해마다 단면 — 회사들 사이에서 ROE 가 P/B 를 얼마나 가르나Annual cross-sections — how much ROE separates P/B across companies年ごとの断面 — 企業間でROEがP/Bをどれだけ分けるか

회사 간 기울기 · % · FY2016~FY2025Cross-company slope · % · FY2016~FY2025企業間の傾き · % · FY2016~FY2025 · Data as of 2026-03 · Created 2026-11-01
FY회사Companies社数중앙 P/BMedian P/BP/B中央値P/B < 1 비율Share with P/B < 1P/B 1倍未満の比率중앙 P/EMedian P/EP/E中央値적자 비율Loss-making share赤字の比率단면 기울기Cross-sectional slope断面の傾き단면 R²Cross-sectional R²断面のR²
20163600.9552%13.96%0.460.25
20173621.1345%15.17%0.540.31
20183630.8758%12.79%0.370.20
20193430.7464%13.015%0.440.22
20203310.8857%14.619%0.560.30
20213680.8362%11.611%0.460.23
20223600.8164%11.013%0.460.24
20233690.9057%13.310%0.500.34
20243750.8661%11.49%0.470.27
20253760.9654%12.58%0.510.30
단면 기울기가 1 이면 모든 회사가 같은 P/E 를 받는 셈이고 0 이면 ROE 와 상관없이 P/B 가 비슷하다. P/B 1 배 미만 비율은 FY2016 52% · FY2022 64% · FY2025 54%(2023년 3월 도쿄증권거래소가 자본비용·주가를 의식한 경영을 요청한 뒤의 변화는 표에서 해마다 본다).A cross-sectional slope of 1 means every company gets the same P/E; 0 means P/B is similar regardless of ROE. The share with P/B below 1x: FY2016 52% · FY2022 64% · FY2025 54% (changes after the Tokyo Stock Exchange’s March 2023 request for management conscious of the cost of capital and share price are tracked year by year in the table).断面の傾きが1ならすべての企業が同じP/Eを受けることになり、0ならROEに関係なくP/Bが似通う。P/B 1倍未満の比率はFY2016 52% · FY2022 64% · FY2025 54%(2023年3月に東京証券取引所が資本コストや株価を意識した経営を要請した後の変化は、表で年ごとに見る)。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Limitations: 해마다 표본 회사가 조금씩 다르다(적자·결산기 변경으로 빠짐) · 3월 결산은 끝나는 해의 앞 해를 FY 로 놓았다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Limitations: The sample of companies differs slightly each year (dropped for losses or changes in fiscal year-end) · for March year-ends, FY is set to the year before the fiscal year ends.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)
Limitations: 標本企業は年ごとに少しずつ異なる(赤字・決算期変更で除外)· 3月決算は終了年の前年をFYとした。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑪ 우리가 보는 일본 종목 — 같은 회귀Japanese stocks we follow — the same regression当サイトがフォローする日本株 — 同じ回帰

캐시된 有報 5년 표Cached 5-year tables from annual securities reportsキャッシュ済みの有報5年表 · Data as of 2026-03 · Created 2026-11-01
종목Stock銘柄업종Sector業種연도Years年数β(그해)β (same year)β(その年)β₃(3년 평균)β₃ (3-year average)β₃(3年平均)P/B 범위P/B rangeP/B範囲P/B 최근Latest P/BP/B直近P/E 최근Latest P/EP/E直近읽기Reading読み
도아고세이Toagosei東亞合成東亞合成東亞合成Toagosei화학 — 전해·아크릴·접착Chemicals — chlor-alkali, acrylics, adhesives化学 — 電解・アクリル・接着14 0.02±0.170.57 0.66~1.030.8214.0중간In between中間
ENEOSENEOS HoldingsENEOSホールディングスENEOSホールディングスENEOSホールディングスENEOS Holdings정유 — 일본 최대 · IFRSRefining — Japan's largest · IFRS石油精製 — 国内最大 · IFRS11 0.06±0.18-0.11 0.49~1.131.1314.7장부(P/B)Book (P/B)簿価(P/B)
이데미쓰Idemitsu Kosan出光興産出光興産出光興産Idemitsu Kosan정유 — 2019 쇼와셸 통합Refining — merged with Showa Shell 2019石油精製 — 2019年に昭和シェルと統合11 0.14±0.150.00 0.48~1.060.9811.0장부(P/B)Book (P/B)簿価(P/B)
코스모Cosmo Energy HoldingsコスモエネルギーホールディングスコスモエネルギーホールディングスコスモエネルギーホールディングスCosmo Energy Holdings정유 — 풍력 겸업Refining — with wind power石油精製 — 風力発電を兼営9 -0.18±0.24-0.31 0.48~1.211.169.8장부(P/B)Book (P/B)簿価(P/B)
후지석유Fuji Oil Company富士石油富士石油富士石油Fuji Oil Company정유 — 단일 정유소Refining — single refinery石油精製 — 製油所1カ所7 0.21±0.11— 0.27~0.470.432.4장부(P/B)Book (P/B)簿価(P/B)
도쿄해상Tokio Marine Holdings東京海上ホールディングス東京海上ホールディングス東京海上ホールディングスTokio Marine Holdings손해보험Non-life insurance損害保険12 0.76±0.111.05 0.82~2.532.5314.2이익(P/E)Earnings (P/E)利益(P/E)
세븐&아이Seven & i Holdingsセブン&アイ・ホールディングスセブン&アイ・ホールディングスセブン&アイ・ホールディングスSeven & i Holdings유통 — 편의점(세븐일레븐)·슈퍼Retail — convenience stores (7-Eleven), supermarkets小売 — コンビニ(セブン-イレブン)・スーパー14 -0.01±0.15-0.08 1.26~1.761.4018.5장부(P/B)Book (P/B)簿価(P/B)
이온AEONイオンイオンイオンAEON유통 — 종합슈퍼(GMS)·쇼핑몰·금융Retail — GMS, shopping malls, financial services小売 — 総合スーパー(GMS)・ショッピングモール・金融13 0.07±0.210.29 0.80~5.065.0682.9장부(P/B)Book (P/B)簿価(P/B)
패스트리테일링(유니클로)Fast RetailingファーストリテイリングファーストリテイリングファーストリテイリングFast Retailing유통 — 의류 SPA(유니클로·GU)Retail — apparel SPA (UNIQLO, GU)小売 — 衣料品SPA(ユニクロ・GU)14 -0.14±0.160.37 4.38~7.106.2933.0중간In between中間
PPIH(돈키호테)Pan Pacific International Holdingsパン・パシフィック・インターナショナルホールディングスパン・パシフィック・インターナショナルホールディングスパン・パシフィック・インターナショナルホールディングスPan Pacific International Holdings유통 — 디스카운트 스토어(돈키호테)Retail — discount stores (Don Quijote)小売 — ディスカウントストア(ドン・キホーテ)14 0.89±0.411.10 2.26~4.893.4922.3이익(P/E)Earnings (P/E)利益(P/E)
니토리Nitori HoldingsニトリホールディングスニトリホールディングスニトリホールディングスNitori Holdings유통 — 가구·인테리어 SPARetail — furniture & home furnishing SPA小売 — 家具・インテリアSPA14 0.64±0.381.50 1.44~4.471.4415.9이익(P/E)Earnings (P/E)利益(P/E)
료힌케이카쿠(무인양품)Ryohin Keikaku (MUJI)良品計画良品計画良品計画Ryohin Keikaku (MUJI)유통 — 생활잡화·의류(무인양품)Retail — lifestyle goods & apparel (MUJI)小売 — 生活雑貨・衣料品(無印良品)13 1.50±0.360.65 1.42~5.665.1033.2중간In between中間
미쓰코시이세탄Isetan Mitsukoshi Holdings三越伊勢丹ホールディングス三越伊勢丹ホールディングス三越伊勢丹ホールディングスIsetan Mitsukoshi Holdings유통 — 백화점Retail — department stores小売 — 百貨店11 0.48±0.060.06 0.72~1.611.6113.3장부(P/B)Book (P/B)簿価(P/B)
재고평가처럼 해마다 크게 흔들리는 이익은 β 를 0 쪽으로 누른다 — 시장이 그 이익에 배수를 안 준다는 뜻이기도 하다. 3년 평균으로 걸러도(β₃) 0 근처면 장부가 닻이다.Profits that swing widely from year to year, such as inventory valuation effects, push β towards 0 — which also means the market does not pay a multiple for those profits. If β stays near 0 even after filtering with a 3-year average (β₃), book value is the anchor.在庫評価のように年ごとに大きく振れる利益はβを0の方へ押し下げる — 市場がその利益に倍率を与えないという意味でもある。3年平均でならしても(β₃)0付近なら、簿価が錨である。

⑫ 측정 한계Measurement limitations測定の限界

1주가는 EPS × PER 로 역산한 기말값 — 적자 해(PER 미기재)는 빠진다. 적자가 잦은 회사일수록 표본에서 약하게 잡힌다.주가는 EPS × PER 로 역산한 기말값 — 적자 해(PER 미기재)는 빠진다. 적자가 잦은 회사일수록 표본에서 약하게 잡힌다.주가는 EPS × PER 로 역산한 기말값 — 적자 해(PER 미기재)는 빠진다. 적자가 잦은 회사일수록 표본에서 약하게 잡힌다.
2회사당 6~10개 연도 — 회사별 β 는 흔들린다. 그래서 분포(중앙값·사분위)로 읽는다. 모은 β 의 표준오차는 연도 간 상관 때문에 과소.회사당 6~10개 연도 — 회사별 β 는 흔들린다. 그래서 분포(중앙값·사분위)로 읽는다. 모은 β 의 표준오차는 연도 간 상관 때문에 과소.회사당 6~10개 연도 — 회사별 β 는 흔들린다. 그래서 분포(중앙값·사분위)로 읽는다. 모은 β 의 표준오차는 연도 간 상관 때문에 과소.
3β < 1 은 '장부 닻'만이 아니라 '일시 이익을 시장이 거른다'로도 나온다 — 3년 평균 β 가 그 둘을 가른다.β < 1 은 '장부 닻'만이 아니라 '일시 이익을 시장이 거른다'로도 나온다 — 3년 평균 β 가 그 둘을 가른다.β < 1 은 '장부 닻'만이 아니라 '일시 이익을 시장이 거른다'로도 나온다 — 3년 평균 β 가 그 둘을 가른다.
4표본은 코드리스트 업종 비례 무작위 — 시가총액 가중이 아니다(지수와 다르다).표본은 코드리스트 업종 비례 무작위 — 시가총액 가중이 아니다(지수와 다르다).표본은 코드리스트 업종 비례 무작위 — 시가총액 가중이 아니다(지수와 다르다).

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)

EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工)

Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage